Hexadecylphosphocholine inhibits phosphatidylinositol and phosphatidylcholine phospholipase C in human leukemia cells

Journal of Experimental Therapeutics and Oncology

Volumn 1, Issue 5, 1996, Pages 302-311

  Berkovic, Dinko ^a   Goeckenjan, Maren ^a   Lüders, Sigrid ^a   Hiddemann, Wolfgang ^a   Fleer, Eduard A M ^a  

^a UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

Author keywords

Alkylphosphocholines; Etherlysophospholipids; Hexadecylphosphocholine; Phospholipase C; Signal transduction

Indexed keywords

ANTINEOPLASTIC AGENT; DRUG DERIVATIVE; FORMYLMETHIONYLLEUCYLPHENYLALANINE; MILTEFOSINE; PHOSPHATIDYLCHOLINE SPECIFIC PHOSPHOLIPASE C; PHOSPHATIDYLCHOLINE-SPECIFIC PHOSPHOLIPASE C; PHOSPHATIDYLINOSITOL DIACYLGLYCEROL LYASE; PHOSPHOLIPASE C; PHOSPHORYLCHOLINE; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL CULTURE; CELL MEMBRANE; DRUG ANTAGONISM; DRUG EFFECT; ENZYME ACTIVATION; ENZYMOLOGY; HUMAN; LEUKEMIA; METABOLISM; THIN LAYER CHROMATOGRAPHY;

ANTINEOPLASTIC AGENTS; CELL MEMBRANE; CELLS, CULTURED; CHROMATOGRAPHY, THIN LAYER; ENZYME ACTIVATION; HUMANS; LEUKEMIA; N-FORMYLMETHIONINE LEUCYL-PHENYLALANINE; PHOSPHATIDYLINOSITOL DIACYLGLYCEROL-LYASE; PHOSPHOLIPASE C; PHOSPHORYLCHOLINE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0030223112     PISSN: 13594117     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Fleer AM, Kim DJ, Nagel GA, Eibl H, Unger C. Cytotoxic activity of lysophosphatidylcholine analogues on human lymphoma Raji cells. Onkologie 13: 295-300, 1990.
2. Unger C. Alkylphosphocholine und Analoga. Entwicklung einer neuen Substanzgruppe mit antineoplastischer Wirkung. Thieme, Stuttgart 1-106, 1989.
3. Hilgard P, Stekar J, Voegeli R, Engel J, Schumacher W, Eibl H, Unger C, Berger MR. Characterization of the antitumor activity of hexadecylphosphocholine (D 18506). Eur J Clin Oncol 24: 1457-1467, 1988.
4. Unger C, Damenz W, Fleer EAM, et al. Hexadecylphosphocholine, a new ether lipid analogue: Studies on the antineoplastic activity in vitro and in vivo. Acta Oncol 28: 213-217, 1989.
5. Scherf HR, Schuler B, Berger MR, Schmäl D. Therapeutic activity of hexadecylphosphocholine against mammary tumors in BD-VI rats. Lipids 22: 927-929, 1987.
6. Eibl H, Unger C. Hexadecylphosphocholine: a new selective antitumor drug. Cancer Treatment Rev 17: 233-242, 1990.
7. Hilgard P, Harleman JH, Voegeli R, Maurer HR, Echarti C, Unger C. The antineoplastic activity of hexadecylphosphocholine is associated with tumor cell differentiation. Proc Am Assoc Cancer Res 30: 3210, 1989.
8. Hochhuth C, Berkovic D, Eibl H, Unger C, Doenecke D. Effects of neoplastic phospholipids on parameters of cell differentiation in U937 cells. J. Cancer Res Clin Oncol 116: 459-466, 1990.
9. Schallier DC, Bruyneel EA, Storme GA, Hilgard P, Mareel MM. Antiinvasive activity of hexadecylphosphocholine in vitro. Anticancer Res 11: 1285-1292, 1991.
10. Zheng B, Oishi K, Shoji M, et al. Inhibition of protein kinase C ( sodium plus potassium)-activated adenosine triphosphatase, and sodium pump by synthetic phospholipid analogues. Cancer Res 50: 3025-3031, 1990.
11. 3 and BM 41.440. Biochem Biophys Res Commun 157: 1000-1006, 1988.
12. Shoji M, Raynor RL, Berdel WE, Vogler WR, Kuo JF. Effects of thioether phospholipid BM 41.440 on protein kinase C and phorbol ester-induced differentiation on human leukemia HL60 and KG-1 cells. Cancer Res 48: 6669-6673, 1988.
13. Kramer IM, van der Bend RL, Tool ATJ, van Blitterswijk WJ, Roos D, Verhoeven AJ. 1-O-hexadecyl-2-O-methylglycerol, a novel inhibitor of protein kinase C, inhibits respiratory burst in human neutrophils. J Biol Chem 264: 5876-5884, 1989.
14. Shoji M, Raynor RL, Fleer EAM, Eibl H, Vogler WR, Kuo JF. Effects of hexadecylphosphocholine on protein kinase C and TPA-induced differentiation of HL60 cells. Lipids 26: 145-149, 1991.
15. Salari H, Dryden P, Davenport R, Howard S, Jones K, Bittman R. Inhibition of protein kinase C by ether-linked lipids is not correlated with their antineoplastic activity on WEHI-3B and R6X-B15 cells. Biochim Biophys Acta 1134: 81-88, 1992.
16. Berkovic D, Berkovic K, Fleer EAM, Eibl H, Unger C. Inhibition of calcium-dependent protein kinase C by hexadecylphosphocholine and 1-O-octadecyl-2-O-methyl-racglycero-3-phosphocholine do not correlate with inhibition of proliferation of HL60 and K562 cell lines. Eur J Cancer 30A: 509-515, 1994.
17. Heesbeen EC, Verdonck LF, Staal GEJ, Rijksen G. Protein kinase C is not involved in the cytotoxic action of 1-O-octadecyl-2-O-methyl-sn-glycero-3-phosphocholine in HL60 and K562 cells. Biochem Pharmacol 47: 1481-1488, 1994.
18. Herrmann DBJ. Changes in cellular lipid synthesis of normal and neoplastic cells during cytolysis induced by alkyl lysophospholipid analogues. J Natl Cancer Inst 75: 219-222, 1985.
19. Vogler WR, Whigham E, Bennett WD, Olson AC. Effect of alkyl-lysophospholipids on phosphatidylcholine biosynthesis in leukemic cell lines. Exp Hematol 13: 629-633, 1985.
20. Modollel M, Andreesen R, Pahlke W, Brugger U, Munder PG. Disturbance of phospholipid metabolism during selective destruction of tumor cells induced by alkyllysophospholipids. Cancer Res 39: 4681-4686, 1985.
21. Berkovic D, Grunwald U, Menzel W, Unger C, Hiddemann W, Fleer EAM. Effects of hexadecylphosphocholine on membrane phospholipid metabolism in human tumour cells. Eur J Cancer 31A: 2080-2085, 1995.
22. Geilen CC, Wieder T, Reutter W. Hexadecylphosphocholine inhibits translation of CTP:cholinephosphate-cytidylyltransferase in Madin-Darby canine kidney cells. J Biol Chem 267: 6719-6724, 1992.
23. 3 does not correlate with the relative effects of the alkyllysophospholipid on the incorporation of fatty acids into cellular phospholipids. Cancer Res 52: 2813-2817, 1992.
24. Lu X, Arthur G. Perturbations of cellular acylation processes by the synthetic alkyl-lysophospholipid 1-O-octadecyl-2-O-methyl-glycero-3-phosphocholine do not correlate with inhibition of proliferation of MCF7 and T84 cell lines. Cancer Res 52: 2806-2812, 1992.
25. 2+ signalling by antitumor ether lipid analogues. Cancer Res 50: 4458-4463, 1990.
26. Powis G, Seewald MJ, Gratas C, Milder DC, Riebow J, Modest EJ. Selective inhibition of phosphatidylinositol phospholipase C by cytotoxic ether lipid analogues. Cancer Res 52: 2835-2840, 1992.
27. Bergren MI, Gallegos A, Dressier LA, Modest EJ, Powis G. Inhibition of the signalling enzyme phosphatidylinositol-3-kinase by antitumor ether lipid analogues. Cancer Res 53: 4297-4302, 1993.
28. Überall F, Oberhuber H, Maly K, Zaknun J, Demuth L, Grunicke HH. Hexadecylphosphocholine inhibits inositol phosphate formation and protein kinase C activity. Cancer Res 51: 807-812, 1991.
29. Kosano H, Takatani O. Reduction of epidermal growth factor binding in human breast cancer cell lines by an alkyllysophospholipid. Cancer Res 49: 2868-2870, 1988.
30. Kosano H, Takatani O. Inhibition by an alkyl-lysophospholipid of the uptake of epidermal growth (EGF) in human breast cancer cell lines in relation to EGF intenalization. Cancer Res 49: 2868-2870, 1989.
31. Shoji M, Fukuhara T, Winton EF, Berdel WE, Vogler WR. Different mechanisms of inhibition by alkyl-lysophospholipid and phorbol ester of granulocyte-macrophage colony stimulating factor binding to human leukemic cell lines. Exp Hematol 22: 13-18, 1994.
32. Bligh EG, Dyer WJ. A rapid method of total lipid extraction and purification. Can J Biochem Physiol 37: 911-917, 1959.
33. Anthes J, Billah MM, Cali A, Egan RW, Siegel MI. Chemotactic peptide, calcium and guanine nucleotide regulation of phospholipase C activity in membranes from DMSO-differentiated HL60 cells. Biochem Biophys Res Commun 145: 825-833, 1987.
34. 2-mediated signalling in neutrophils. Biochim Biophys Acta 1113: 135-160, 1992.
35. Schütze S, Berkovic D, Tomsing O, Unger C, Krönke M. Tumor nercrosis factor induces rapid production of 1,2 diacylglycerol by a phosphatidylcholine-specific phospholipase C. J Exp Med 174: 975-988, 1991.
36. Fleer EAM, Berkovic D, Eibl H, Unger C. Investigations on the cellular uptake of hexadecylphosphocholine. Lipids 28: 731-736, 1993.
37. Pawelczyk T, Lowenstein JM. Inhibition of phospholipase C δ by hexadecylphosphopholine and lysophospholipids with antitumor activity. Biochem Pharmacol 45: 493-497, 1993.
38. Ries U, Fleer EAM, Unger C, Eibl H. Synthetic phospholipids as substrates for phospholipase C from Bacillus cereus. Biochim Biophys Acta 1125: 166-170, 1992.
39. Fleer EAM, Unger C, Kim DJ, Eibl H. Metabolism of ether phospholipids and analogues in neoplastic cells. Lipids 22: 856-861, 1987.
40. 3 acts as an activator of protein kinase C in HL60 cells. FEBS Letters 290: 231-234, 1991.
41. Dahlgren C, Andersson T, Stendahl O. Chemotactic factor binding and functional capacity: a comparison between human granulocytes and differentiated HL60 cells. J Leukocyte Biol 42: 245-252, 1987.
42. Perianin A, Gougerot-Pocidalo M-A, Giroud J-P, Hakim J. Diclofenac binding to human polymorphonuclear neutrophils: effects on respiratory burst and N-formylated peptide binding. Biochem Pharmacol 36: 2609-2615, 1987.
43. Scheurich P, Ücer U, Kränke M, Pfizenmaier K. Quantification and characterization of high-affinity membrane receptors for tumor necrosis factor on human leukemic cell lines. Int J Cancer 38: 127-133, 1986.
44. 125I-labeled recombinant human tumor necrosis factor to cell surface receptors. J Biochem 100: 531-541, 1986.
45. Hohmann HO, Remy R, Brockhaus M, van Loon APGM. Two different cell types have different major receptors for hunian tumor necrosis factor. J Biol Chem 264: 14927-14932, 1990.
46. Loetscher H, Pan YCE, Lahm HW, Gentz R, Brockhaus M, Tabuchi H, Lesslauer W. Molecular cloning and expression of the human 55 kd tumor necrosis factor receptor. Cell 62: 351-359, 1990.
47. Thoma B, Grell M, Rizenmaier K, Scheurich P. Identification of a 60-kD tumor necrosis factor (TNF) receptor as the major signal transducing component in TNF responses. J Exp Med 172: 1019-1027, 1990.
48. Rath HM, Doyle GAR, Silbert DF. Hamster fibroblast defective in thrombin induced mitogenesis. J Biol Chem 264: 13387-13390, 1989.
49. Smith MR, Liu Y-L, Kim H, Rhee SG, Kung HF. Inhibition of serum- and ras-stimulated DNA synthesis by antibodies to phospholipase C. Science 247: 1074-1077, 1990.
50. Margolis B, Zilberstein A, Franks C, Felder S, Kremer S, Ullrich A, Rhee SG, Skorecki K, Schlessinger J. Effect of phospholipase C-g overexpression on PDGF-induced second messengers and mitogenesis. Science 248: 607-616, 1990.